CDKN2A and breast cancer: Copy-number changes concordant to human breast cancer can be recognized, e.g. gains in at least three tumors were detected for TERT and NF1. Furthermore, in accordance with human data TP53, MAP2K4 and CDKN2A/B were deleted in two of canine tumors.